APA citiranje

Schenone, A. D., Luo, J., Montgomery, L., Morgensztern, D., Adkins, D. R., & Van Tine, B. A. (2014). Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy. BlackWell Publishing Ltd.

Citação norma Chicago

Schenone, Aaron D., Jingqin Luo, Luke Montgomery, Daniel Morgensztern, Douglas R. Adkins, and Brian A. Van Tine. Risk-stratified Patients With Resectable Soft Tissue Sarcoma Benefit From Epirubicin-based Adjuvant Chemotherapy. BlackWell Publishing Ltd, 2014.

MLA citiranje

Schenone, Aaron D., et al. Risk-stratified Patients With Resectable Soft Tissue Sarcoma Benefit From Epirubicin-based Adjuvant Chemotherapy. BlackWell Publishing Ltd, 2014.